Autor: |
Adovich S. Rivera, Omar Al-Heeti, Lucia C. Petito, Mathew J. Feinstein, Chad J. Achenbach, Janna Williams, Babafemi Taiwo |
Jazyk: |
angličtina |
Rok vydání: |
2023 |
Předmět: |
|
Zdroj: |
BMC Infectious Diseases, Vol 23, Iss 1, Pp 1-11 (2023) |
Druh dokumentu: |
article |
ISSN: |
1471-2334 |
DOI: |
10.1186/s12879-023-08026-0 |
Popis: |
Key points Question Is statin use prior to hospital admission for COVID-19 associated with reducing severe inpatient outcomes? Findings In this observational study using electronic health records from a multi-hospital health system in Chicago, we used robust statistical methods to account for confounding and found that adults 40 years or older who were prescribed statins prior to admission for COVID-19 had minimally lower rates of intubation and admission to the intensive care unit. However, inpatient mortality was comparable between statins users and non-users. Meaning Consistent with current COVID-19 treatment guidelines, we did not find evidence supporting the utilization of statins for clinically significant reduction in severe inpatient COVID-19 outcomes. |
Databáze: |
Directory of Open Access Journals |
Externí odkaz: |
|
Nepřihlášeným uživatelům se plný text nezobrazuje |
K zobrazení výsledku je třeba se přihlásit.
|